DOSE-RANGING IN CLINICAL-TRIALS - RATIONALE AND PROPOSED USE WITH PLACEBO OR POSITIVE CONTROLS

被引：0
|
作者：
FRESTON, JW
机构：
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 1986年 / 81卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：307 / 311
页数：5
相关论文
共 50 条
  • [41] Scientific and ethical issues in the use of placebo and active controls in clinical trials
    Ellenberg, SS
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) : 1121 - 1124
  • [42] PHARMACOKINETICALLY GUIDED DOSE ESCALATION IN PHASE-I CLINICAL-TRIALS - COMMENTARY AND PROPOSED GUIDELINES
    NEWELL, DR
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (07): : 1083 - 1087
  • [43] Indomethacin Pharmacokinetics and Pharmacodynamics in Pregnancies With Preterm Labor: The Need for Dose-Ranging Trials
    Balevic, Stephen J.
    Weiner, Daniel
    Hornik, Christoph P.
    Cohen-Wolkowiez, Michael
    Gonzalez, Daniel
    Wang, Xiaoming
    Xu, Meixiang
    Abdel-Rahman, Sherif Z.
    Rytting, Erik
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (06): : 728 - 736
  • [44] Adaptive and Model-Based Dose-Ranging Trials: Quantitative Evaluation and Recommendations. White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Studies
    Pinheiro, Jose
    Sax, Frederic
    Antonijevic, Zoran
    Bornkamp, Bjorn
    Bretz, Frank
    Chuang-Stein, Christy
    Dragalin, Vladimir
    Fardipour, Parvin
    Gallo, Paul
    Gillespie, William
    Hsu, Chyi-Hung
    Miller, Frank
    Padmanabhan, S. Krishna
    Patel, Nitin
    Perevozskaya, Inna
    Roy, Amit
    Sanil, Ashish
    Smith, Jonathan R.
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2010, 2 (04): : 435 - 454
  • [45] Software to compute and conduct sequential Bayesian phase I or II dose-ranging clinical trials with stopping rules
    Zohar, S
    Latouche, A
    Taconnet, M
    Chevret, S
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2003, 72 (02) : 117 - 125
  • [46] A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia
    Tack, J.
    Masclee, A.
    Heading, R.
    Berstad, A.
    Piessevaux, H.
    Popiela, T.
    Vandenberghe, A.
    Kato, H.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (03): : 272 - 280
  • [47] PLACEBO-EFFECT AND CLINICAL-TRIALS IN MIGRAINE THERAPY
    COUCH, JR
    NEUROEPIDEMIOLOGY, 1987, 6 (04) : 178 - 185
  • [48] THE PLACEBO CONTROL IN CLINICAL-TRIALS (A VIEW FROM THE FDA)
    LEBER, P
    PSYCHOPHARMACOLOGY BULLETIN, 1986, 22 (01) : 30 - 32
  • [49] ASPECTS OF THE INTERPRETATION OF PLACEBO-CONTROLLED CLINICAL-TRIALS
    MULLER, AA
    BINZ, U
    WENDT, G
    PHARMACOPSYCHIATRY, 1985, 18 (01) : 127 - 128
  • [50] UNETHICAL PLACEBO ASSIGNMENT IN CLINICAL-TRIALS OF THROMBOLYSIS - REPLY
    MUNKVAD, S
    JESPERSEN, J
    GRAM, J
    KLUFT, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (05) : 1303 - 1303
12345